Clinical Study of 18F-Alfatide Injection PET/CT

NCT06416852 · clinicaltrials.gov ↗

PHASE3

Phase

NOT_YET_RECRUITING

Status

428

Enrollment

INDUSTRY

Sponsor class

Conditions

Non-Small Cell Lung Cancer NSCLC

Interventions

DRUG: 18F-Alfatide Injection
DRUG: 18F-FDG Injection

Sponsor

Yantai LNC Biotechnology Singapore PTE. LTD.